212 related articles for article (PubMed ID: 18330954)
1. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
He YW; Guo CX; Pan YF; Peng C; Weng ZH
World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
[TBL] [Abstract][Full Text] [Related]
4. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
[TBL] [Abstract][Full Text] [Related]
7. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
[TBL] [Abstract][Full Text] [Related]
8. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells.
Xin XM; Li GQ; Jin YY; Zhuang M; Li D
World J Gastroenterol; 2008 Jun; 14(24):3849-54. PubMed ID: 18609708
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
10. [Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2 cells].
Tang N; Huang AL; Zhang BQ; Yan G; Xiang MQ; Pu D; Guo H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):464-6. PubMed ID: 12939176
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
12. [The effects of different PAP domains on hepatitis B virus replication].
Guo CX; He YW; Peng C; Lei YC; Li WT
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):105-8. PubMed ID: 20196948
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication.
Karamese M; Aydogdu S; Karamese SA; Altoparlak U; Gundogdu C
Asian Pac J Cancer Prev; 2015; 16(10):4199-202. PubMed ID: 26028072
[TBL] [Abstract][Full Text] [Related]
15. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
16. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
[TBL] [Abstract][Full Text] [Related]
18. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
19. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
20. Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.
Xu WZ; Fang Y; Li D; Wang Y; Shang QL; Li GQ; Teng X; Gu HX
World J Gastroenterol; 2008 Jun; 14(23):3733-8. PubMed ID: 18595141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]